Patents by Inventor Avraham Liav

Avraham Liav has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6303764
    Abstract: The present invention provides an improved method of preparing a 4,7-di-O-alkyl chromogenic ketoside of N-acetylneuraminic acid (Neu5Ac) for use in detecting influenza virus types A and B. The ketosides are substrates that are selectively cleaved by a neuraminidase on influenza virus, but not be neuraminidases found on other viruses or on bacteria. The synthesis is efficient and provides large quantities of the ketoside for commercial development. The synthesis includes a step of alkylating the 4- and 7-hydroxyl groups of a protected alkyl ester alkyl ketoside derivative of Neu5Ac by a process that comprises contacting the derivative with a composition comprising an alkyl halide to form a 4,7-di-O-alkyl protected alkyl ester alkyl ketoside derivative of Neu5Ac. The synthesis alternatively includes protecting the 8- and 9-hydroxyl groups of an alkyl ester alkyl ketoside derivative of Neu5Ac by forming an 8,9-epoxide protected alkyl ester alkyl ketoside derivative of Neu5Ac.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: October 16, 2001
    Assignees: Zymetx, Inc., Palladin Opportunity Fund, LLC, Halifex Fund, L.P.
    Inventors: Om Srivastava, Geeta Srivastava, Minghui Du, Ole Hindsgaul, David R. Bundle, Avraham Liav
  • Patent number: 5766841
    Abstract: A kit for visually detecting the presence of a virus in a direct clinical specimen is provided. The kit employs a rapid and direct assay for visually detecting a virus having a characteristic enzyme in a direct clinical sample without the need for any culturing step, This assay contains the following steps: (1) the clinical sample is contacted in solution with a substrate for the enzyme which includes a chromogen that is cleaved from the substrate by the enzyme and a precipitating agent which reacts with the liberated chromogen to form a precipitate, (2) the precipitate is concentrated, and (3) the concentrated precipitate is visually observed for the characteristic color of the chromogen. The observance of the characteristic color confirms the presence of the virus in the clinical specimen.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 16, 1998
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Avraham Liav, Craig D. Shimasaki, James F. Maher, C. Worth Clinkscales, Michael D. Roark
  • Patent number: 5719020
    Abstract: Chromogenic and fluorogenic 4,7-dialkoxy-N-acetylneuraminic acid substrates of the general formula ##STR1## are provided wherein R.sub.1 and R.sub.2 are alkyl groups containing 1 to 4 carbon atoms and R.sub.3 is a chromogenic or fluorogenic group. These substrates can be used to detect influenza types A and B in clinical samples or specimens. More particularly, these 4,7-dialkoxy-N-acetylneuraminic acid substrates can be used to distinguish between various viruses having neuraminidase reactivity. Thus, influenza type A and B viruses can be distinguished from parainfluenza type 1, 2, 3, and 4, and mumps using the 4,7-dialkoxy-N-acetylneuraminic acid derivatives of this invention. Diagnostic methods employing these substrates are provided to identify influenza type A and B viruses in clinical specimens and to distinguish from other viruses having neuraminidase reactivity.
    Type: Grant
    Filed: September 25, 1996
    Date of Patent: February 17, 1998
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Avraham Liav, Joyce Anne Hansjergen, Craig David Shimasaki
  • Patent number: 5556963
    Abstract: This invention relates to an improved process for the synthesis of 4-alkoxy-N-acetylneuraminic acids. According to the process of the invention, N-acetylneuraminic acid is first alkylated at C-1 and C-2 and then the vicinal hydroxyl groups at C-8 and C-9 are protected through the formation of a ketal. The resulting protected alkyl ester alkyl ketoside is then alkylated at the C-4 position whereby the hydrogen of the C-4 hydroxyl group is replaced with an alkyl group to form an alkoxy group. Deprotection is accomplished through the removal of the ketal group at C-8 and C-9 and removal of the alkyl groups at C-1 and C-2, thereby producing the 4-alkoxy-N-acetylneuraminic acid.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: September 17, 1996
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Avraham Liav, Ragen F. Hardgrave, Sheri Blystone, Gregory A. Turner
  • Patent number: 5252458
    Abstract: A rapid and direct assay for detecting of a virus having a characteristic enzyme in clinical samples in which (1) the clinical sample is contacted in solution with a substrate for the enzyme which includes a chromogen that is cleaved from the substrate by the enzyme and a precipitating agent that reacts with the liberated chromogen to form a precipitate (2) filtering the solution to concentrate the precipitate and (3) visually observing the concentrated precipitate for the characteristic color of the chromogen.
    Type: Grant
    Filed: October 16, 1992
    Date of Patent: October 12, 1993
    Assignee: Symex Corp.
    Inventors: Avraham Liav, James F. Maher, Craig D. Shimasaki, C. Worth Clinkscales, Michael D. Roark
  • Patent number: 4835264
    Abstract: A new method for the production of 3,6-Di-O-methyl-D-glucose is presented.
    Type: Grant
    Filed: December 12, 1986
    Date of Patent: May 30, 1989
    Assignee: National Jewish Center
    Inventors: Avraham Liav, Mayer B. Goren
  • Patent number: 4307229
    Abstract: An improved process is described for synthesizing simple and complex 6,6'-diacyl esters of trehalose and intermediates useful therein. Novel 6,6'-diacyl esters of trehalose and novel intermediates useful in the process of the invention are also disclosed. The inventive process is capable of producing the desired compounds economically and in pure form from readily available starting materials.
    Type: Grant
    Filed: November 7, 1979
    Date of Patent: December 22, 1981
    Inventors: Avraham Liav, Mayer B. Goren